✦ LIBER ✦

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901

✍ Scribed by R Paridaens; J Dyczka; E.J.T Rutgers; R Coleman; T Cufer; J Jassem; J.W.R Nortier; L Morales; M.R Mattiacci; P Therasse

Book ID: 118622000
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 172 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)90652-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postoperative adjuvant chemotherapy foll

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: A randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group

✍ Leilani Morales; Peter Canney; Jaroslaw Dyczka; Emiel Rutgers; Robert Coleman; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 201 KB

First results of a randomized phase III

First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) — EORTC 10951 in collaboration with the exemestane working group and NCIC Clinical Trials Group

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

Systemic chemotherapy following non-cura

Systemic chemotherapy following non-curative resection may increase survival for people with gall bladder carcinoma, but not carcinomas of the pancreas, bile duct or ampulla of Vater: Abstracted from: Takada T, Amano H, Yasuda H et al. Is postoperative adjuvant chemotherapy useful for gall bladder carcinoma? A phase III multicentre prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002; 95(8): 1685–95.

✍ Kazuhiro Hanazaki 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 66 KB